The Genetic Puzzle of Familial Atrial Fibrillation

Area of Science:

• Cardiology
• Genetics
• Epidemiology

Background:

• Atrial fibrillation (AF) is the most common tachyarrhythmia, with significant projected increases in prevalence and healthcare burden.
• While risk factors are known, up to 30% of AF cases lack identifiable causes, highlighting the role of genetics.
• Familial atrial fibrillation (FAF) has been studied since 1936, with recent molecular genetics advances identifying numerous variants.

Purpose of the Study:

• To review epidemiological studies on FAF.
• To identify common and rare genetic variants associated with FAF.
• To discuss the clinical implications of these variants and their role in personalized medicine.

Main Methods:

• Review of epidemiological studies on familial atrial fibrillation.
• Analysis of identified common and rare genetic variants.
• Discussion of clinical implications and therapeutic strategies.

Main Results:

• Advances in molecular genetics have identified multiple common and rare variants linked to FAF.
• Understanding FAF contributes to identifying individuals at high risk.
• FAF research is crucial for developing targeted management and personalized therapies.

Conclusions:

• Genetic factors play a significant role in atrial fibrillation, particularly in cases without clear risk factors.
• Identifying FAF variants is key to early detection and risk stratification.
• Further research into FAF genetics will drive the development of personalized therapeutic strategies for atrial fibrillation.